Related Experiment Videos

HID and KID syndromes are associated with the same connexin 26 mutation

M van Geel1, M A M van Steensel, W Küster

  • 1Department of Dermatology, University Hospital Nijmegen, The Netherlands. m.vangeel@derma.azn.nl

Insights

Keratitis-ichthyosis-deafness (KID) and hystrix-like ichthyosis-deafness (HID) syndromes are genetically identical. Mutation analysis of the connexin 26 (GJB2) gene confirms both conditions share the same molecular basis.

Area of Science:

  • Genetics
  • Dermatology
  • Otolaryngology

Background:

  • Keratitis-ichthyosis-deafness (KID) syndrome is a rare genetic disorder characterized by erythrokeratoderma, sensorineural deafness, and an increased risk of squamous cell carcinoma.
  • A specific missense mutation in the connexin 26 (GJB2) gene has been identified as a cause of KID syndrome.
  • Hystrix-like ichthyosis-deafness (HID) syndrome presents with similar clinical features to KID syndrome, with distinctions historically based on electron microscopy.

Observation:

  • This study investigated the genetic relationship between KID and HID syndromes.
  • DNA from the first described HID syndrome patient was analyzed for mutations in the connexin 26 (GJB2) gene.
  • The researchers utilized polymerase chain reaction and restriction enzyme analysis, a method sensitive to the specific mutation causing KID syndrome.

Findings:

  • Mutation analysis revealed that the HID syndrome patient carries the identical connexin 26 (GJB2) mutation previously identified in KID syndrome patients.
  • Direct DNA sequencing confirmed the presence of the KID syndrome mutation in the HID syndrome DNA sample.
  • These molecular findings demonstrate that HID and KID syndromes are indistinguishable at the genetic level.

Implications:

  • The study concludes that KID and HID syndromes are molecularly identical, supporting the clinical suspicion that they represent the same condition.
  • Phenotypic variations previously used to distinguish these syndromes may be attributed to sampling artifacts or genetic background effects, such as concurrent mutations in other genes.
  • This finding has implications for accurate diagnosis and potential therapeutic strategies targeting the shared molecular pathway in affected individuals.
Abstract

Related Concept Videos